Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

Posdinemab works by targeting and neutralizing Alzheimer disease-specific phosphorylated tau, preventing its spread to other neurons.

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

Johnson & Johnson (JNJ) announced that the FDA has granted Fast Track designation to its Posdinema, a monoclonal antibody ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

Even as new drugs come to market, further study appears to point to infections as a possible cause for the debilitating ...

Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, ...

Learn about early-onset Alzheimer's through real stories of hope and breakthrough treatments that are changing lives of patients diagnosed before age ...

Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, ...

The treatment is not a permanent fix for Alzheimer's dementia, Jing said, because the disease will eventually ... It's important for them to know there are options out there." ...